Quintiles Russia

Last updated: 13.02.2014

Address: Quintiles GesmbH, Leningradskiy prospekt 37A, bldg. 14, floor 4, 125167 Moscow, Office complex ARCUS,Russia

Tel: + 7 495 721 1964

Web: http://www.quintiles.com/locations/europe/Russia/

Company description

• Quintiles started operations in Russia in 1996
• First office opened in Moscow in 1997;
• Office in St. Petersburg opened in 2005;
• Office in Novosibirsk, centre of Siberian region of Russia, opened in 2007.
• 226 professional employees in total (119 in Moscow, 89 in St. Petersburg, 18 in Novosibirsk);
• Russia has centralized medical care system, common standards across the country, qualified and experienced investigators;
• 93% of staff has an university degree. Within clinical staff 56% of employees have MD degree;
• Quintiles Russia provides wide range of services including site ID and feasibility, SSU together with RA, clinical monitoring, GFR, PCC. Starting from 2010 we began our expansion in commercialization;
• Quintiles has well established relationship with regulatory bodies and also key opinion leaders across the country – which allows representation in all regions of Russia and Quintiles appears to be the leading CRO in Russia, based on the number of initial trial submissions during the year.
• Key drivers of clinical trial market in the country – governmental focus on innovative technologies including pharmaceutical industry, continued growth and further high potential of clinical research market in Russia
• Key advantages – strong and long-term Quintiles experience on country level, common medical standards and practices across the country, direct access to a network of high professional sites and investigators, high recruitment potential in wide range of indications including naïve patients, centralized submission/approval process

Products and services

• Clinical services
• Commercial services
• Consulting
• Capital (investment)



We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here